Pancreatic Cancer Research

ResearcherIndiana University HealthActive in the last 2 years

Alexander Starodub

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110147506. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 5

  1. Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer. Co-author DOI 10.1038/s41591-026-04537-w↗
  2. Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer. Co-author DOI 10.1056/nejmoa2505783↗
  3. Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I … Last author DOI 10.1634/theoncologist.2020-0474↗
  4. Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated … Co-author DOI 10.1007/s10637-018-0650-5↗
  5. (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior ther… Co-author DOI 10.1016/j.ejca.2015.06.119↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wungki Park · 2 shared papers, 2026 · strength 0.41
  2. Brian Matthew Wolpin · 2 shared papers, 2026 · strength 0.41
  3. Minal A. Barve · 2 shared papers, 2026 · strength 0.41
  4. David S. Hong · 2 shared papers, 2026 · strength 0.41
  5. Ignacio Garrido‐Laguna · 2 shared papers, 2026 · strength 0.41
  6. Alexander I. Spira · 2 shared papers, 2026 · strength 0.41
  7. Joel Randolph Hecht · 1 shared paper, 2026 · strength 0.23
  8. Nilofer Saba Azad · 1 shared paper, 2026 · strength 0.23
  9. Kyaw Lwin Aung · 1 shared paper, 2026 · strength 0.23
  10. Ashenafi Shiferaw Bulle · 1 shared paper, 2026 · strength 0.18
  11. Julien Dilly · 1 shared paper, 2026 · strength 0.18
  12. Ida Aronchik · 1 shared paper, 2026 · strength 0.18
  13. Urszula N. Wasko · 1 shared paper, 2026 · strength 0.18
  14. Andrew J. Aguirre · 1 shared paper, 2026 · strength 0.18
  15. Kian‐Huat Lim · 1 shared paper, 2026 · strength 0.18
  16. Anirban Maitra · 1 shared paper, 2026 · strength 0.18
  17. Mallika Singh · 1 shared paper, 2026 · strength 0.18
  18. Andrew Eugene Hendifar · 1 shared paper, 2019 · strength 0.10
  19. Kimmie Ng · 1 shared paper, 2019 · strength 0.10
  20. William C. Hahn · 1 shared paper, 2019 · strength 0.10
  21. Charles S. Fuchs · 1 shared paper, 2019 · strength 0.10
  22. Zev A. Wainberg · 1 shared paper, 2020 · strength 0.09
  23. Manish R. Patel · 1 shared paper, 2020 · strength 0.09
  24. Jordan D. Berlin · 1 shared paper, 2020 · strength 0.09
  25. Johanna C. Bendell · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.